Leonard L. Gordon, advertising and marketing group leader with Venable LLP, explains the Federal Trade Commission’s recent action on verifying “Made in USA” claims for a wide range of manufactured products.

Are manufacturers engaged in a mass exodus from China? And if so, where are they going?

Are we finally seeing the end of the longest freight recession in recent decades? It’s the question on everyone’s mind — and has been for over a year. 

Global investors are lasered onto China’s struggling economy, even as they also contemplate the possibility of a recession in the U.S.

The concept behind Foreign-Trade Zones (FTZs) is not hard to grasp — they act as secured places for receiving cargo into the U.S. without incurring tariffs, yet. Then, there are multiple ways those tariffs can be reduced. And yet, many companies are failing to make the most of FTZs to reduce costs, because they’re intimidated by the legal and organizational hurdles.

Thailand and other Southeast Asian countries have seen an influx of trash from developed countries, from dirty plastic to industrial and electronic waste.

Canada's Industrial Labor Board ruled on August 9 that there are no critical shipments that would be required to continue in the event of a strike.

Manufacturers are now asking whether they should reach further back in the chain, in their pursuit of both resilience and growth opportunities.

If you’re looking to get a glimpse into the future of technology for managing the pharmaceutical cold chain, pay attention to where investors are placing their bets.